SBFM — Sunshine Biopharma Inc.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1402328 ·
Last close
$0.42
Market Cap
$6.73M
52W High
$2.32
52W Low
$0.28
ADV30
26,746,712
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 8,088,765 | 2,180,990 | -1,395,597 | -1,243,869 | 27,930,375 | 6,913,013 | 6,413,781 |
| Dec 2025 | 8,577,141 | 3,028,845 | -1,658,223 | -2,140,927 | 30,079,167 | 9,123,308 | 7,040,707 |
| Sep 2025 | 9,417,179 | 3,073,540 | -531,963 | -883,820 | 31,487,379 | 9,306,438 | 7,288,023 |
| Jun 2025 | 9,410,230 | 3,422,866 | -992,846 | -1,770,834 | 31,965,250 | 10,305,320 | 6,280,446 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-5,331,073
Investing CF
$-836,306
Financing CF
$4,748,408
CapEx
$-836,306
Dividends Paid
—
Buybacks
$0
EPS Diluted TTM
$-1.96
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-75,015,126
Inventory
$13,472,025
Receivables
$3,459,864
ST Investments
—
EBIT TTM
$-5,953,743
Pretax Income TTM
$-5,953,743
Interest Exp TTM
$0
Analysts
1
Yahoo Snapshot (yfinance, live)
Total Revenue
$35,493,316
EBITDA
$-4,234,493
Free Cash Flow
$-4,710,076
Enterprise Value
$-3,745,811
Total Cash
$6,913,013
Total Debt
$744,840
Shares Out
16,165,945
Trailing EPS
$-1.25
Book Value
$4.69
ROE
-27.3%
ROA
-10.0%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 36,305,891 | -4,478,782 | -5,975,352 | 30,079,167 | 7,040,707 | — | -5,331,073 |
| Dec 2024 | 34,874,283 | -5,812,121 | -5,134,116 | 30,560,392 | 7,059,638 | — | -12,524,779 |
| Dec 2023 | 24,092,787 | -4,785,299 | -4,506,044 | 27,346,961 | 6,139,600 | — | -8,775,111 |
| Dec 2022 | 4,345,603 | -8,674,031 | -26,744,440 | 29,243,848 | 7,616,278 | — | -5,248,358 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$199.80
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| SILO | Silo Pharma, Inc. | $6.69M | $0.41 | — |
| PCSA | Processa Pharmaceuticals, Inc. | $6.88M | $2.50 | — |
| ASBP | Aspire Biopharma Holdings, Inc. | $6.57M | $5.07 | — |
| SYBX | SYNLOGIC, INC. | $7.02M | $0.60 | — |
| XBIO | Xenetic Biosciences, Inc. | $7.02M | $3.07 | — |
News headlines (Yahoo Finance, 1h cache)
Sunshine Biopharma Receives Canadian Regulatory Approval for Generic Amoxicillin
2026-05-21 11:00 · Yahoo
Sunshine Biopharma Inc. Announces Closing of up to $18.0 Million Public Offering
2026-05-19 16:05 · Yahoo
Sunshine Biopharma Inc. Announces Pricing of $6.0 Million Public Offering
2026-05-18 16:15 · Yahoo
Sunshine Biopharma Reports Fiscal 2025 Revenue of $36.3 Million, a 4.1% Increase Over Prior Year
2026-04-06 12:30 · Yahoo
Sunshine Biopharma Scores a Major Regulatory Win to Market Domperidone in Canada (NASDAQ: SBFM)
2025-10-28 18:10 · Yahoo
Sunshine Biopharma Gains FDA-Equivalent Clearance in Canada for Domperidone to Treat Cancer-related Nausea
2025-10-28 11:45 · Yahoo
Sunshine Biopharma Launches STD, Acne and Lyme Disease Therapy Doxycycline
2025-10-20 11:45 · Yahoo
Sunshine Biopharma Launches Cholesterol Fighting Medicine Pravastatin
2025-10-16 11:45 · Yahoo
Sunshine Biopharma is Proving That Riding Momentum is an Effective Strategy (NASDAQ:SBFM)
2025-10-14 14:45 · Yahoo
Sunshine Biopharma Proves Microcap Ambition Can Deliver Large-Cap Level Execution (NASDAQ: SBFM)
2025-10-14 12:50 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.